Immunoblot (IB) assays were developed for detection of rubella virus (RV)-specific immunoglobulin G (IgG), IgM, and IgA antibodies in human serum following natural infection or immunization. IB assays performed under nonreducing conditions were compared with those performed under reducing conditions and with immunoprecipitation assays. Significant loss of antigenicity (>90%) of RV El and E2 proteins was observed when IB assays were performed in the presence of 2-mercaptoethanol as compared with assays under nonreducing conditions. In contrast, the antigenicity of RV capsid protein was not influenced by reducing agents. Sensitivity of IB for RV-specific IgG antibodies was determined to be 0.01 IU/ml under nonreducing conditions. In the determination of RV-specific IgM and IgA antibodies by IB, pretreatment of serum with protein G to remove competing high-affinity RV-specific IgG or rheumatoid factor significantly improved assay sensitivity. IB assays were observed to be superior to immunoprecipitation assays in their ability to better define the specificities of RV-specific antibodies and to detect antibodies of all immunoglobulin classes. However, the conformational sensitivity of RV protein antigenicity should be an important consideration in the interpretation of RV-specific antibodies by IB assays.
Rubella virus (RV), the sole member of the genus Rubivirus of the family Togavindae, is of clinical significance due to its capacity to induce congenital malformation and persistent infection in the human fetus when exposure occurs during the first trimester of pregnancy (44) . RV infection or immunization occurring postnatally may also give rise to chronic manifestations such as arthralgia, arthritis, and neurologic sequelae (12, 30, 38) thought to arise from RV persistence in host tissues. Most RV infections produce lifetime immunity mediated by circulating antibodies and specific T lymphocytes (13, 27) . However, immunity to RV is most frequently ascertained by detection of specific antibodies by enzyme-linked immunosorbent assay (ELISA) or other immunoassay methods which employ whole virus. RV contains three major structural proteins which are antigenic in both animals and humans: the envelope glycoproteins, El and E2, and the capsid (C) protein, which is associated with the viral RNA (8, 34, 42) . Epitopes involved in hemagglutination and neutralization have been identified on El with the aid of RV-specific murine monoclonal antibodies (17, 19, 41) , and El appears to be immunodominant in the normal serologic response to RV (19) . An additional weak neutralization domain on E2 was also described (13) . Although to date no other biological roles have been ascribed to the E2 or C protein, there is increasing interest in these proteins as indicators of abnormal responses to RV (7) . Katow and Sugiura (19) demonstrated that although antibodies to El were predominant following most RV infections, anti-E2 antibodies were relatively more abundant following congenital infection. We have also observed abnormal distributions of anti-El, -E2, and -C reactivities in RV hemagglutination inhibition-or ELISA-seronegative individuals developing arthritis in close temporal association with RV infection or immunization (26, 38) , suggesting that previous RV exposure was associated with a failure to develop or sustain functional immunity. Similar dissociations between seroconversion and development of effective immunity to RV have been reported by others (15, 18, 36) , indicating a need for a more sensitive and specific method of serodiagnosis.
The fine specificities of RV antibodies have been analyzed by immunoprecipitation (IP) followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (26) . However, this procedure is laborious, time-consuming, and hazardous in that it utilizes radiolabelled virus, and it is usually limited to detecting antibodies of the immunoglobulin G (IgG) class only. Immunoblot (IB) assays which are simpler to perform can be used to determine not only the specificities of antibodies generated in response to RV infection or immunization but also their class distribution. As detection of RV-specific IgM antibodies is critical to the diagnosis of maternal RV exposure and congenital rubella and may be used as a criterion for recommending therapeutic abortion, more-sensitive and -definitive methods for detecting this class of antibody are continually being sought. Whole-RV ELISAs. ELISAs for RV-specific IgG, IgA, and IgM antibodies were performed as previously described (38) . Briefly, detergent-solubilized RV (M33) prepared as described above was diluted optimally in bicarbonate-carbonate coating buffer (pH 9.6) and coated onto polystyrene microplates overnight at 4°C. After blocking the virus-coated wells with PBS (pH 7.4) containing 0.5% (wt/vol) bovine serum albumin for 1 h at room temperature, patient serum (diluted 1:100 to 1:1,600) or reference serum (diluted to give concentrations ranging from 0.062 to 1.0 IU/ml) was added and the microplates were incubated for 1 h at 37°C. The plates were then washed four times in PBS containing 0.05% (vol/vol) Tween 20, and optimally diluted alkaline phosphatase-conjugated goat anti-human IgG, IgA, or IgM antisera (affinity purified y, a*, or ,u chain specific; Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) were added to the wells correspondingly. After a second 1-h incubation at 37°C, the plates were washed in PBS containing 0.05% Tween 20 as described above and enzyme substrate (-nitrophenyl phosphate, 2 mg/ml in diethanolamine-Mg + buffer, pH 9.8) was added to the wells. The A405 was determined with a Bio-Rad (Richmond, Calif.) model 3550 microplate reader. Results were calculated by linear regression and interpolation from standard curves prepared with the reference sera described above.
SDS-PAGE and IB assay. SDS-PAGE was performed with 0.75-mm minigels (Mini-Protean; Bio-Rad) by using a discontinuous buffer system (as described by Laemmli [22] ) and 10% polyacrylamide separating gels. Virus preparations were diluted 1:1 with sample buffer (60 mM Tris, 2% SDS, 10% glycerol, 0.02% bromophenol blue, pH 6.8) either with 1% 2-mercaptoethanol (reducing) or without mercaptoetha- with blot strips at 4°C overnight and washed in washing buffer for 1 h. Optimal dilutions of alkaline phosphataseconjugated affinity-purified goat anti-human IgG, IgM, and IgA (Kirkegaard & Perry Laboratories) were added, correspondingly, and the strips were incubated at room temperature for 2 h with gentle mixing. After washing as described above, the strips were incubated in 30 ml of substrate solution (pH 9.5; 100 mM Tris-5 mM MgCl2-100 mM NaCl containing 5 mg of bis-chloroindoylphosphate and 10 mg of nitroblue tetrazolium [dissolved in 100 and 70% formamide, respectively]) to visualize RV protein bands. Densitometric tracings on the IB strips were made with a Video Densitometer 620 (Bio-Rad), and the relative density (optical density in millimeters [OD mm]) of each band was determined by integration of the area under each peak. Relative amounts (R%) of antibody binding to El, E2, and C were expressed as a percentage of the absorbance area of each peak compared with the total area under all peaks and were calculated according to the following formula: R% = [OD mm (peak X)/OD mm (peak El + E2 + C)] x 100.
Radioimmunoprecipitation. A modification of the conventional protein A-Sepharose technique (26) was used for radioimmunoprecipitation. Briefly, protein A-Sepharose suspension (Pharmacia) was washed in TBS containing 1%
Triton X-100 and resuspended in a minimal volume of the same buffer. Patient or control serum (30 ,ul) diluted in 200 ,ul of TBS-Triton X-100 was added to 50 ,ul of washed protein A-Sepharose suspension, and the mixture was allowed to adsorb to the protein A with gentle mixing for 4 h at 4°C. The beads were then washed well in TBS-Triton X-100, [35S]methionione-labelled detergent-solubilized RV (41) was added in a total volume of 200 pul, and the mixture was incubated for 4 h or overnight at 4°C. After washing the beads well by centrifugation through TBS-Triton X-100 followed by TBS, precipitated proteins were eluted from the protein A-Seph-VOL. 30, 1992 observed at 58 kDa (El), 42 to 47 kDa (E2), and 66 kDa (C dimer) in blots performed after SDS-PAGE in the absence of 2-mercaptoethanol (data not shown). Higher-molecularmass bands thought to be El homodimers and El-E2 heterodimers were also observed. When NC blots were developed with sera obtained from three subjects 6 months after immunization with RV RA 27/3 vaccine (Fig. 1) , strong reactivities were observed with El and E2 proteins in blots performed under nonreducing conditions. In marked contrast, it was observed that the addition of 2-mercaptoethanol to the SDS-PAGE sample buffer destroyed much of the antigenicity of El and to a lesser extent that of E2, while C protein antigenicity was relatively unaffected.
In a separate experiment (Fig. 2) , the relative sensitivities of RV IgG lBs performed under reducing ( Fig. 2A) It was observed that in samples with high levels (>1,000 IU/ml) of RV-specific IgG antibody (as measured by ELISA) the binding of specific IgM and IgA antibodies was significantly inhibited in both ELISA and IB. Figure 3 and Table 1 depict representative results with a serum sample before and after protein G treatment showing that RV-specific IgM and IgA antibodies could be more effectively measured in both ELISA (Table 1) and IB (Fig. 3) after removal of serum IgG.
To determine the efficiency of protein G adsorption of serum IgG, patient sera and RV IgG, IgM, and IgA reference sera before and after protein G treatment were serially diluted, subjected to SDS-PAGE, and electrophoretically transferred to NC membranes. Isotype-specific bands were detected with enzyme-conjugated anti-human IgG, IgM, and IgA antisera. After densitometric scanning of the developed blots, the relative absorbances of isotype bands observed Percentage of total cumulative area measured as optical density in millimeters (OD mm) under all peaks as determined by densitometry. Serum numbers correspond to those shown in Fig. 4. ing natural infection, sequential serum samples taken during the early acute, acute, and convalescent phases (see Materials and Methods) after onset of rash were subjected to IB. It was observed that in three serum samples (Fig. 5) anti-El IgG and IgA antibodies appeared during the acute phase (7 to 30 days postonset) and persisted throughout the follow-up period of 1 to 3 years after initial infection. Anti-C antibodies of all three immunoglobulin classes were detected in acutephase sera but had disappeared by 1 to 3 years postinfection. Anti-E2 antibodies of the IgG and IgA classes were not detected until 1 month after onset, and these were observed to increase in the convalescent-phase samples. IgM reactivity with El, E2, and C was observed only in acute-phase sera. DISCUSSION identified for this protein. However, the predominance of E2-specific antibodies in patients with altered immunity to RV (19) has sparked interest in the potential role of this protein in RV-associated pathology.
Detection of RV-specific IgM antibodies is an important criterion for diagnosis of acute and possibly persistent RV infection. RV-specific IgM determinations have been used in the early postnatal period to confirm congenital RV infection (33, 37) . Detection of RV-specific IgA antibodies in serum has been of interest with respect to their associations either with prevention of reinfection (14) or as indicators of persistent RV infection (29) . Unfortunately, assays for RVspecific IgM and IgA antibodies often lack sensitivity and specificity because of interference from high-affinity RVspecific IgG antibodies which may compete for antigen binding (2) or from IgM anti-IgG rheumatoid factors or heterophile antibodies which may give rise to false-positive results, particularly in ELISAs and other solid-phase assays (4, 23, 28, 33, 35) . A further problem encountered in determination of RV-specific IgM is reported cross-reactivity of antibodies with other pathogens, such as parvovirus (21) , which may be observed in acute-phase sera in particular. As seroconversion to RV-specific IgM is taken as an indicator of RV exposure in pregnant women and may be a criterion for recommending pregnancy termination, it is critical that these problems of sensitivity and specificity be overcome. These potential problems should also be borne in mind when p.atiLe 1 EaliUntW2 PatLet 3_
The majority of investigations which have analyzed the fine specificity of RV-directed antibodies have employed either IP (26, 31) or SDS-PAGE under reducing conditions followed by IB (3, 5, 6, 31, 43) to detect RV-specific IgG antibodies. Apart from being time-consuming, laborious, and hazardous because of the use of radioactively labelled virus, IP techniques have been limited by their capacity to detect RV-specific antibodies within the IgG class only. A further limitation of this methodology has been in its potential for false-positive interpretation of E2-reactive antibodies in serum due to coprecipitation of E2 as El-E2 dimers reacting with El-specific antibodies (16, 41, 42) . Furthermore, the disproportional distribution of methionines in the RV structural proteins has to be corrected for during densitometric analysis, if [35S] methionine is used as a metabolic labelling agent. El contains only three methionines, whereas E2 and C contain seven and six, respectively (3), resulting in the underestimation of El in the immunoprecipitate. In the present study, notable differences were observed between the distribution of antibody specificities in a given serum sample as determined by IP or IB assay. In the present study, the relatively larger percentages of E2-specific antibodies detected by IP compared with those detected by IB suggest that coprecipitation of E2 as El-E2 heterodimers may indeed lead to erroneous interpretations of E2 antibody specificity when the former method is used. Although epitopes on E2 may be masked by the association of this protein with El in the viral envelope in intact RV (42) , during processing and presentation of RV antigens to the immune system such epitopes may give rise to detectable antibodies, as monoclonal antibody studies have shown (43) . Apart (8, 41) . The sensitivity of El and E2 to reducing conditions may be due to damage to discontinuous epitopes which are present on the native virus. Katow and Sugiura (20) observed that 2-mercaptoethanol significantly reduced RV hemagglutinin activity by inducing conformational changes in RV envelope proteins. Both El and E2 are rich in cysteine residues (3) which are likely involved in maintaining tertiary structure through intrachain disulfide bonding. Hence, the disruption of disulfide bonds and loss of tertiary structure would be expected to destroy at least some of the antigenicity of El and E2, as was observed in the present study. In contrast, C protein contains only two cysteine residues, of which one is involved in intrachain bonding. Thus, it is likely to display mostly linear (continuous) epitopes and hence would be more resistant to reducing treatment, as was also observed in this study. Therefore, we conclude that nonreducing SDS-PAGE should be used routinely in RV IB assays to preserve RV protein antigenicity and to improve assay sensitivity.
It is becoming increasingly evident that more-sensitive and -specific methodology is required for serodiagnosis of recent RV infection and for determining seroconversion after RV vaccination. There are numerous reports in the literature which illustrate dissociation between the results of RV serologic tests and vaccine failure as determined by RV reinfection or associated pathology. For example, it has been shown that certain individuals deemed seronegative by RV hemagglutination inhibition and neutralizing antibody assays had antibodies reactive with electrophoretically purified E2 and C proteins in ELISA with little or no reactivity with El protein (26, 39) , suggesting previous exposure to RV with failure to develop functional immunity. Other studies (24, 32) have documented reinfection in rubella hemagglutination inhibition-seropositive individuals who contracted wild RV infection. Also, recent observations of molecular mimicry resulting in RV-induced autoimmunity (45) have increased interest in the fine specificities of the RV immune response. The enhanced sensitivity and specificity afforded by the RV IB assays described herein will be useful not only for detection of recent RV infections and differentiation of borderline-positive seroconversion in the management of congenital RV infection but also for dissecting the fine specificity of the anti-RV antibody response and its relationship to effective immunity.
